Who is the manufacturer of VELYS Robotic-Assisted Solution?

Depuy Ireland UC filed the 510(k) submission for VELYS Robotic-Assisted Solution (K202769).

What is the FDA product code for VELYS Robotic-Assisted Solution?

OLO. It is classified under 21 CFR 882.4560 as a Class 2 device in the Neurology panel.

What is the regulatory pathway for VELYS Robotic-Assisted Solution?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like VELYS Robotic-Assisted Solution?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

VELYS Robotic-Assisted Solution

K202769 · Depuy Ireland UC · OLO · Jan 14, 2021 · Neurology

Device Facts

Record ID	K202769
Device Name	VELYS Robotic-Assisted Solution
Applicant	Depuy Ireland UC
Product Code	OLO · Neurology
Decision Date	Jan 14, 2021
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 882.4560
Device Class	Class 2
Attributes	Therapeutic

Intended Use

The VELYS™ Robotic-Assisted Solution is intended for stereotaxic surgery to aid the surgeon in identifying the relative position and orientation of anatomical structures, planning the femoral and tibial implant components intraoperatively, and preparing the bones during total knee arthroplasty. The VELYS™ Robotic-Assisted Solution is indicated for use with the ATTUNE Total Knee System and its cleared indications for use.

Device Story

Image-free robotic-assisted surgery system for TKA; uses optical tracking to acquire intraoperative anatomical landmarks; surgeon plans femoral/tibial implant positions via GUI; system uses motorized robotic arm to constrain saw handpiece/blade within planned resection planes; provides real-time dynamic compensation for patient leg movement; used in OR by surgeons; surgeon manually actuates saw handpiece; output includes visual navigation, surgical planning, and bone resection guidance; benefits include improved accuracy and alignment of implant components.

Clinical Evidence

No clinical tests were conducted. Evidence is based on non-clinical bench testing, including performance testing, electrical safety (IEC 60601-1), EMC (IEC 60601-1-2), biocompatibility (ISO 10993-1), and sterilization validation. Accuracy and repeatability studies confirmed performance equivalent to the predicate. Simulated use testing performed on sawbones and cadavers.

Technological Characteristics

Image-free optical tracking system; motorized robotic arm; touchscreen/footswitch interface; connectivity via base/satellite stations. Complies with IEC 60601-1, IEC 60601-1-2, IEC 80601-2-77, ASTM F2554-18, and ASTM F3107-14. Sterilization per ISO 11137. Software-driven resection planning and real-time dynamic compensation.

Indications for Use

Indicated for patients undergoing total knee arthroplasty (TKA) requiring stereotaxic surgical assistance for anatomical landmark identification, implant component planning, and bone preparation, specifically for use with the ATTUNE Total Knee System.

Regulatory Classification

Identification

A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.

Predicate Devices

TOTAL KNEE SURGETICS Navigation System with iBlock (K090953)

Related Devices

K233227 — VELYS Robotic-Assisted Solution · Depuy Ireland UC · Dec 14, 2023
K213873 — SkyWalker Total Knee System · Microport Navibot International, LLC · Jul 7, 2022
K240211 — VELYS Robotic-Assisted Solution · Depuy Ireland UC · Jun 5, 2024
K260010 — TMINI® Miniature Robotic System · THINK Surgical, Inc. · Mar 3, 2026
K241031 — TMINI Miniature Robotic System (TMINI 1.1) · THINK Surgical, Inc. · Jul 12, 2024

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath in a smaller font. January 14, 2021 DePuy Ireland UC Stéphanie Elvin Regulatory Affairs Manager Loughbeg, Ringaskiddy Ireland Re: K202769 Trade/Device Name: VELYSTM Robotic-Assisted Solution Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO Dated: December 18, 2020 Received: December 22, 2020 Dear Stephanie Elvin: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal {1}------------------------------------------------ statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K202769 Device Name VELYSTM Robotic-Assisted Solution #### Indications for Use (Describe) The VELYS™ Robotic-Assisted Solution is intended for stereotaxic surgery to aid the surgeon in identifying the relative position and orientation of anatomical structures, planning the femoral and tibial implant components intraoperatively, and preparing the bones during total knee arthroplasty. The VELYS™ Robotic-Assisted Solution is indicated for use with the ATTUNE Total Knee System and its cleared indications for use. Type of Use (Select one or both, as applicable) | <div> ☒ Prescription Use (Part 21 CFR 801 Subpart D) </div> | |-----------------------------------------------------------------------------------------------------------------------------------------| | <div> ☐ Over-The-Counter Use (21 CFR 801 Subpart C) </div> | ## CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # 510(k) SUMMARY (As required by 21 CFR 807.92) | Submitter Information | | |---------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Name | DePuy Ireland UC | | Address | Loughbeg, Ringaskiddy Co. Cork Munster, IRELAND | | Phone number | 574-372-7211 | | Fax number | 574- 371-4987 | | Establishment Registration Number | 3015516266 | | Name of contact person | Stéphanie Elvin selvin@jnj.its.com, Karen Mahoney kmahoney@its.jnj.com | | Date prepared | 18 December 2020 | | Name of device | | | Trade or proprietary name | VELYSTM Robotic-Assisted Solution | | Common or usual name | Surgical Navigation System | | Classification name | Orthopedic Stereotaxic Instrument | | Class | II | | Classification panel | 87 Orthopedics | | Regulation | 882.4560 | | Product Code(s) | OLO | | Legally marketed device(s) to which equivalence is claimed | TOTAL KNEE SURGETICS Navigation System with iBlock (K090953) | | Reason for 510(k) submission | New Device | | Device description | The VELYSTM Robotic-Assisted Solution is an image-free robotic-assisted surgery system for Total Knee Arthroplasty (TKA). It is intended for stereotaxic surgery to aid the surgeon in identifying the relative position and orientation of anatomical structures and landmarks, planning the position of the femoral and tibial implant components intraoperatively, and preparing the bones during total knee arthroplasty. The image-free system uses a dedicated optical tracking device to acquire anatomical landmarks intra-operatively. These landmarks are then used to plan the femoral and tibial implant locations based on the surgeon's preferred surgical technique and placement preferences. Following the planning step, the VELYSTM Robotic-Assisted Solution helps the surgeon to execute the bone preparation according to the plan. | | Indications for use | The system includes a Robotic-Assisted Device that constrains the position and orientation of the saw handpiece and blade inside each plane corresponding to each resection on the patient's femur and tibia. The surgeon actuates and manipulates the saw handpiece, within the planned resection plane, to execute the bone resection. This is analogous to using manual instruments in TKA and the way the surgeon uses the saw handpiece in the predicate device. If the patient's leg moves during the resection, the Robotic- Assisted Device compensates for such movement in real-time. The Robotic-Assisted Device is assembled with a Robotic-Assisted Device arm, mounted on the Operating Room (OR) bed rail, for a minimal footprint. The VELYSTM Robotic-Assisted Solution incorporates several software sub- systems, including applications responsible for general operation of the system and a Clinical Application dedicated to the surgery workflow. The users interact with the Clinical Application via a touchscreen and footswitch to navigate through the surgery steps. Case Reports including key surgical procedure information are stored on the system and can be retrieved by the surgeon for future use. The VELYSTM Robotic-Assisted Solution is intended for stereotaxic surgery to aid the surgeon in identifying the relative position and orientation of anatomical structures, planning the position of the femoral and tibial implant components intraoperatively, and preparing the bones during total knee arthroplasty. The VELYSTM Robotic-Assisted Solution is indicated for use with the ATTUNE Total Knee System and its cleared indications for use. | {4}------------------------------------------------ {5}------------------------------------------------ | Summary of the Technological Characteristics of the Device Compared to the Predicate Device | | | |---------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Characteristics | Subject Device: VELYSTM Robotic-Assisted Solution DePuy Ireland UC | Predicate Device: Total Knee Surgetics Navigation System with iBlock, OMNILife Science Inc. K090953 Cleared Jan 21, 2010 | | Indications for Use | The VELYSTM Robotic-Assisted Solution is intended for stereotaxic surgery to aid the surgeon in identifying the relative position and orientation of anatomical structures, planning the position of the femoral and tibial implant components intraoperatively, and preparing the bones during total knee arthroplasty. The VELYSTM Robotic-Assisted Solution is indicated for use with the ATTUNETM Total Knee System and its cleared indications for use. | The Total Knee Surgetics Navigation System with iBlock is intended for use during stereotaxic surgery to aid the surgeon in locating anatomical structures and aligning endoprostheses with the anatomical structures. The Total Knee Surgetics Navigation System with iBlock is specifically indicated for Total Knee Arthroplasty | | Principles of operation | Uses established computer-assisted orthopaedic surgery technologies to prepare the bone Optical localization technology is used to collect intraoperative data and track relative position of the bones and instruments during surgery A motorized instrument controlled by the system automatically positions the resection plane (saw blade) within the planned plane for the bone resection and maintains alignment through dynamic compensation. Image-free technology | Uses established computer-assisted orthopaedic surgery technologies to prepare the bone Optical localization technology is used to collect intraoperative data and track relative position of the bones and instruments during surgery A motorized instrument controlled by the system automatically positions the resection plane (cutting guide) to the planned plane for the bone resection. Image-free technology | | Stations | Base station: camera, power supply, Robot Control Unit, display monitor, foot pedal Satellite station: optional touchscreen, storage for Robotic-Assisted Device and Robotic-Assisted Device arm, transfer mechanism to assist with transfer to bedrail | One station: camera, power supply unit, control box for robot, computer unit, display monitor, foot pedal | | Software | Dedicated TKA application software | Dedicated TKA application software | {6}------------------------------------------------ #### Discussion of Similarities and Differences Between the Device and the Predicate Device The VELYS™ Robotic-Assisted Solution (Subject device) and the TOTAL KNEE SURGETICS Navigation System with iBlock (Predicate device) have the same intended use and are both indicated for TKA surgery. Both devices are image-free and use Stereotaxic / Computer Assisted Surgery (CAS) technology to localize bone structures and track their position relative to the instruments during surgery. The systems use very similar setups with one or two stations holding a camera, computer units, power supply, and display monitors; dedicated instruments sets, containing in arrays with reflective markers; and instruments such as drill pins and clamps for attaching arrays to the bones. The VELYS™ Robotic-Assisted Solution includes a dedicated cabled Saw Handpiece. Operation of the systems is very similar; the surgeon registers bone anatomy using a pointer, the system software provides a visual bone model and allows the surgeon to plan resections. Based on the surgical plan, the system positions either a cutting guide (in the predicate) or the Saw Handpiece (for the subject device) in the correct position to allow the surgeon to execute the planned resection. The surgical flows are very similar, and the surgeon can choose the order of cuts to perform via the Graphic User Interface (GUI). Surgical techniques provided with the proposed and predicate devices are specific to the implants they are indicated for use with. The devices differ slightly in the way they provide a resection plane. In the predicate device, a cutting guide is positioned by a motorized instrument and the surgeon places the sawblade through the slot in the guide to perform the resection. In the subject device, a motorized instrument holds the Saw Handpiece in the correct plane for the surgeon to execute the primary resections; there is no physical cutting guide, the cutting guide is effectively virtualized. Software in the subject device establishes the desired resection plane, tracks the positioning of Arrays in real-time and adjusts the position of the Saw Blade to compensate for any movement of the patient leg. In the predicate device, the cutting guide is mounted on the patient's femur to ensure the cutting guide position is maintained relative to the bone. #### Performance Data ## Summary of Non-Clinical Tests Conducted for Determination of Substantial Equivalence Design verification tests were performed on the VELYS™ Robotic-Assisted Solution in accordance with the product risk analysis and product requirements and to demonstrate substantial equivalence to the predicate device. Testing performed for assessing device performance include Performance Testing, Electrical Safety, Electromagnetic Compatibility, Biocompatibility, Sterilization, Packaging, Transport, Software and Usability. Simulated use testing included testing on simulated knees (sawbones) and cadavers. Users included surgeons and Operating Room staff, who were able to successfully use the VELYS™ Robotic-Assisted Solution to implant ATTUNE Total Knee System per specification. {7}------------------------------------------------ Testing was performed that demonstrated compliance to the following standards: AAMI ANSI ISO 11137-1:2006 (R) 2015 Sterilization of healthcare products - Radiation Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices ISO 11137-2:2013 Sterilization of health care products - Radiation Part 2: Establishing the sterilization dose ISO 11607-1:2019 Packaging for Terminally Sterilized Medical Devices – Part 1: Requirements for Materials, Sterile Barrier Systems and Packaging Systems ISO 11607-2:2019 Packaging for Terminally Sterilized Medical Devices - Part 2: Validation Requirements for Forming. Sealing and Assembly Processes. ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process IEC 60601-1:2005 + A1:2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance AAMI ES60601-1:2005 and A1:2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance IEC 60601-1-2:2014 Medical electrical equipment - Part 2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests IEC 80601-2-77:2019 Particular requirements for the BASIC SAFETY and essential performance of ROBOTICALLY ASSISTED SURGICAL EQUIPMENT ASTM F2554-18 Standard Practice for Measurement of Positional Accuracy of Computer Assisted Surgical Systems ASTM F3107-14 Standard Test Method for Measuring Accuracy after Mechanical Disturbances on Reference Frames of Computer Assisted Surgery Systems Subject and predicate devices were tested to the same international standards for key requirements such as Electrical Safety and EMC, as well as Biocompatibility, supporting substantial equivalence. In addition to standard-driven testing, the following test was performed to compare the system navigation accuracy and support substantial equivalence to the predicate: - Accuracy and repeatability study, which concluded the system localization accuracy of the subject is . the same as the predicate. {8}------------------------------------------------ The following tests were performed to support Safety and Efficacy of the proposed device as they pertain to features specific to the proposed device: - Dynamic-compensation performance test. ● - Accuracy test bench study to confirm the accuracy of the saw blade position. . - . Boundary Limit Essential Performance test. - . Cadaveric Accuracy study to confirm resection accuracy compared to conventional instruments. - . Design Validation study. Non-Clinical testing supports Substantial Equivalence of the subject device VEL YS™ Robotic-Assisted Solution to the predicate device TOTAL KNEE SURGETICS Navigation System with iBlock # Summary of Clinical Tests Conducted for Determination of Substantial Equivalence and/or of Clinical Information No clinical tests were conducted to demonstrate substantial equivalence. ## Conclusions Drawn from Non-Clinical and Clinical Data The subject VELYS™ Robotic-Assisted Solution is substantially equivalent to the predicate TOTAL KNEE SURGETICS Navigation System with iBlock.